| 000 | 01795 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518000612.0 | ||
| 264 | 0 | _c20190924 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1872-7980 | ||
| 024 | 7 |
_a10.1016/j.canlet.2018.09.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeip, Kotryna | |
| 245 | 0 | 0 |
_aStroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment. _h[electronic resource] |
| 260 |
_bCancer letters _c12 2018 |
||
| 300 |
_a1-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdaptation, Physiological _xdrug effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCancer-Associated Fibroblasts _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCoculture Techniques |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 700 | 1 | _aJørgensen, Kjetil | |
| 700 | 1 | _aHaselager, Marco Vincent | |
| 700 | 1 | _aAlbrecht, Marco | |
| 700 | 1 | _aHaugen, Mads Haugland | |
| 700 | 1 | _aEgeland, Eivind Valen | |
| 700 | 1 | _aLucarelli, Philippe | |
| 700 | 1 | _aEngebraaten, Olav | |
| 700 | 1 | _aSauter, Thomas | |
| 700 | 1 | _aMælandsmo, Gunhild Mari | |
| 700 | 1 | _aPrasmickaite, Lina | |
| 773 | 0 |
_tCancer letters _gvol. 439 _gp. 1-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2018.09.023 _zAvailable from publisher's website |
| 999 |
_c28860292 _d28860292 |
||